 |
| Low platelet levels in patients suffering from blood cancers and other conditions reduce the ability to form clots. LightIntegra claims that its dynamic light scattering technology is better able to classify the activity of of platelet samples from blood donors than conventional approaches. Image via thrombocyte.com. |
| © 2024 SPIE Europe |
|
